Effects of severe hypertension on endothelial and platelet microparticles

被引:433
作者
Preston, RA
Jy, W
Jimenez, JJ
Mauro, LM
Horstman, LL
Valle, M
Aime, G
Alm, YS
机构
[1] Univ Miami, Dept Med, Div Clin Pharmacol, Sch Med, Miami, FL 33136 USA
[2] Univ Miami, Wallace H Coulter Platelet Lab, Dept Med, Sch Med, Miami, FL 33136 USA
关键词
hypertension; arterial; endothelium; platelets; endothelium-derived factors; cell adhesion molecules;
D O I
10.1161/01.HYP.0000049760.15764.2D
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
The molecular mechanisms by which extreme blood pressure elevation leads to vascular injury are not defined. To explore the hypothesis that activation of endothelium and platelets as manifested by increased concentrations of circulating endothelial microparticles and platelet microparticles could play a role in this target organ injury, we conducted a cross-sectional study of these markers in 3 groups: (1) untreated patients referred specifically for treatment of severe uncontrolled hypertension; (2) untreated patients with established mild hypertension; and (3) normotensive volunteer subjects. By ANOVA, endothelial (P=0.002) and platelet (P=0.01) microparticles were greatest in the severely hypertensive group. There was a significant correlation between both of these markers and blood pressure, even in the setting of multiple risk factors. Our results suggest that these markers may be useful and specific for pressure-induced endothelial and platelet activation in hypertension. Furthermore, because of the combined effects of endothelial and platelet microparticles on coagulation, leukocytes, and endothelium, it is possible that they may play a pathogenic role in mediating target organ injury in severe hypertension.
引用
收藏
页码:211 / 217
页数:7
相关论文
共 52 条
[1]   EFFECTS OF TREATMENT ON MORBIDITY IN HYPERTENSION - RESULTS IN PATIENTS WITH DIASTOLIC BLOOD PRESSURES AVERAGING 115 THROUGH 129 MM HG [J].
不详 .
JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1967, 202 (11) :1028-&
[2]  
[Anonymous], 1997, ARCH INTERN MED, V157, P2413, DOI DOI 10.1001/ARCHINTE.1997.00440420033005
[3]   Mechanisms of cellular activation by platelet microparticles [J].
Barry, OP ;
FitzGerald, GA .
THROMBOSIS AND HAEMOSTASIS, 1999, 82 (02) :794-800
[4]   Transcellular activation of platelets and endothelial cells by bioactive lipids in platelet microparticles [J].
Barry, OP ;
Pratico, D ;
Lawson, JA ;
FitzGerald, GA .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (09) :2118-2127
[5]   Modulation of monocyte-endothelial cell interactions by platelet microparticles [J].
Barry, OP ;
Praticò, D ;
Savani, RC ;
FitzGerald, GA .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 102 (01) :136-144
[6]   Evidence of platelet activation in hypertension [J].
Blann, AD ;
Lip, GYH ;
Islim, IF ;
Beevers, DG .
JOURNAL OF HUMAN HYPERTENSION, 1997, 11 (09) :607-609
[7]   Circulating microparticles from patients with myocardial infarction cause endothelial dysfunction [J].
Boulanger, CM ;
Scoazec, A ;
Ebrahimian, T ;
Henry, P ;
Mathieu, E ;
Tedgui, A ;
Mallat, Z .
CIRCULATION, 2001, 104 (22) :2649-2652
[8]   EVIDENCE FOR ALTERED PLATELET NITRIC-OXIDE SYNTHESIS IN ESSENTIAL-HYPERTENSION [J].
CADWGAN, TM ;
BENJAMIN, N .
JOURNAL OF HYPERTENSION, 1993, 11 (04) :417-420
[9]   Decreased nitric oxide levels and increased calcium content in platelets of hypertensive patients [J].
Camilletti, A ;
Moretti, N ;
Giacchetti, G ;
Faloia, E ;
Martarelli, D ;
Mantero, F ;
Mazzanti, L .
AMERICAN JOURNAL OF HYPERTENSION, 2001, 14 (04) :382-386
[10]  
Chalmers J, 1999, J HYPERTENS, V17, P151